• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症预防概述:化学预防与免疫预防

An Overview of Cancer Prevention: Chemoprevention and Immunoprevention.

作者信息

Gu Kyle J, Li Guojun

机构信息

Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

College of Natural Sciences, The University of Texas at Austin, Austin, TX, USA.

出版信息

J Cancer Prev. 2020 Sep 30;25(3):127-135. doi: 10.15430/JCP.2020.25.3.127.

DOI:10.15430/JCP.2020.25.3.127
PMID:33033707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7523034/
Abstract

Cancer prevention encompasses a broad spectrum of strategies designed to lower the chance of developing cancer and reduce the morbidity of established cancer. There are three levels of cancer prevention. Eliminating or mitigating cancer risk factors by adopting healthy behaviors and lifestyles, such as avoiding tobacco and alcohol use, exercising, eating a healthy diet, and applying sunscreen to protect against UV exposure, belongs to primary prevention and is the easiest and most effective way of preventing cancer for the general public. Secondary prevention includes screening to identify precancerous lesions and taking intervention measures to prevent disease progression to malignancy. Tertiary prevention refers to reducing or controlling the symptoms and morbidity of established cancer or the morbidity caused by cancer therapy. For high-risk populations, chemopreventive agents, such as selective estrogen receptor modulators (including tamoxifan and raloxifene) in breast cancer prevention and non-steroidal anti-inflammatory drugs (aspirin) in colorectal cancer prevention, and immunoprevention using human papillomavirus and hepatitis B virus vaccines in infection-related cancers have shown clear clinical benefits of reducing cancer incidences. In this review, we will summarize the current status of cancer prevention, focusing on the major agents that are clinically used for chemoprevention and immunoprevention.

摘要

癌症预防涵盖了广泛的策略,旨在降低患癌几率并减少已确诊癌症的发病率。癌症预防有三个层面。通过采取健康的行为和生活方式来消除或减轻癌症风险因素,比如避免吸烟饮酒、锻炼身体、保持健康饮食以及涂抹防晒霜以防止紫外线照射,这属于一级预防,是普通大众预防癌症最简单且最有效的方式。二级预防包括筛查以识别癌前病变,并采取干预措施防止疾病发展为恶性肿瘤。三级预防是指减轻或控制已确诊癌症的症状和发病率,或减轻癌症治疗所导致的发病率。对于高危人群,化学预防剂,如用于预防乳腺癌的选择性雌激素受体调节剂(包括他莫昔芬和雷洛昔芬)以及用于预防结直肠癌的非甾体抗炎药(阿司匹林),还有在与感染相关癌症中使用人乳头瘤病毒和乙肝病毒疫苗进行免疫预防,都已显示出在降低癌症发病率方面有明确的临床益处。在本综述中,我们将总结癌症预防的现状,重点关注临床上用于化学预防和免疫预防的主要药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4347/7523034/1c707aa6df18/JCP-25-127-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4347/7523034/049e173299b8/JCP-25-127-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4347/7523034/1c707aa6df18/JCP-25-127-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4347/7523034/049e173299b8/JCP-25-127-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4347/7523034/1c707aa6df18/JCP-25-127-f2.jpg

相似文献

1
An Overview of Cancer Prevention: Chemoprevention and Immunoprevention.癌症预防概述:化学预防与免疫预防
J Cancer Prev. 2020 Sep 30;25(3):127-135. doi: 10.15430/JCP.2020.25.3.127.
2
Vaccines and other immunological approaches for cancer immunoprevention.癌症免疫预防的疫苗和其他免疫方法。
Curr Drug Targets. 2011 Dec;12(13):1957-73. doi: 10.2174/138945011798184146.
3
Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.阿司匹林及其他非甾体抗炎药在结直肠癌预防中的应用
Important Adv Oncol. 1996:123-37.
4
Recent advances in cancer chemoprevention, with emphasis on breast and colorectal cancer.癌症化学预防的最新进展,重点关注乳腺癌和结直肠癌。
Eur J Cancer. 2000 Apr;36(6):694-709. doi: 10.1016/s0959-8049(00)00040-x.
5
Cancer Immunoprevention: Current Status and Future Directions.癌症免疫预防:现状与未来方向。
Arch Immunol Ther Exp (Warsz). 2021 Feb 27;69(1):3. doi: 10.1007/s00005-021-00604-x.
6
Preventing cancer: dietary lifestyle or clinical intervention?预防癌症:饮食生活方式还是临床干预?
Asia Pac J Clin Nutr. 2002;11 Suppl 3:S618-31. doi: 10.1046/j.0964-7058.2002.00337.x.
7
Chemoprevention of breast cancer.乳腺癌的化学预防
Expert Rev Anticancer Ther. 2008 Mar;8(3):443-52. doi: 10.1586/14737140.8.3.443.
8
Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.高危女性及导管原位癌患者的乳腺癌化学预防
Breast J. 2015 Jul-Aug;21(4):377-86. doi: 10.1111/tbj.12418. Epub 2015 Apr 16.
9
Chemoprevention of colorectal cancer: ready for routine use?结直肠癌的化学预防:准备好常规使用了吗?
Recent Results Cancer Res. 2005;166:213-30. doi: 10.1007/3-540-26980-0_14.
10
Chemoprevention of breast cancer.乳腺癌的化学预防
Am J Health Syst Pharm. 2008 Dec 1;65(23):2221-8. doi: 10.2146/ajhp070663.

引用本文的文献

1
Exploring Dietary and Lifestyle Profiles in Colorectal Cancer Patients: Hypothesis-Generating Insights for Tertiary Prevention.探索结直肠癌患者的饮食和生活方式概况:三级预防的假设生成性见解
Cancers (Basel). 2025 Aug 14;17(16):2654. doi: 10.3390/cancers17162654.
2
Comprehensive Screening for Early Cancer Detection in Individuals With Genetic Predisposition.对具有遗传易感性个体进行早期癌症检测的综合筛查。
JCO Precis Oncol. 2025 Aug;9:e2500333. doi: 10.1200/PO-25-00333. Epub 2025 Aug 20.
3
Recent strategies in diagnosis, screening, prevention, and treatment of breast cancer in young women.

本文引用的文献

1
Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidence.根据美国国立综合癌症网络(NCCN)指南及证据水平对美国食品药品监督管理局(FDA)批准的免疫检查点抑制剂适应症的综述。
Cancers (Basel). 2020 Mar 20;12(3):738. doi: 10.3390/cancers12030738.
2
Cancer Immunoprevention: A Case Report Raising the Possibility of "Immuno-interception".癌症免疫预防:一例“免疫阻断”可能性病例报告。
Cancer Prev Res (Phila). 2020 Apr;13(4):351-356. doi: 10.1158/1940-6207.CAPR-19-0528.
3
Cancer statistics, 2020.癌症统计数据,2020 年。
年轻女性乳腺癌诊断、筛查、预防及治疗的最新策略
Discov Oncol. 2025 Aug 11;16(1):1532. doi: 10.1007/s12672-025-03180-0.
4
Utilizing miR-34a-Loaded HER2-Targeting Exosomes to Improve Breast Cancer Treatment: Insights From an Animal Model.利用负载miR-34a的HER2靶向外泌体改善乳腺癌治疗:来自动物模型的见解
J Breast Cancer. 2025 Mar 14. doi: 10.4048/jbc.2024.0262.
5
Hereditary Breast Cancer: Comprehensive Risk Assessment and Prevention Strategies.遗传性乳腺癌:综合风险评估与预防策略
Genes (Basel). 2025 Jan 13;16(1):82. doi: 10.3390/genes16010082.
6
Molecular Targets of Plant-Derived Bioactive Compounds in Oral Squamous Cell Carcinoma.植物源生物活性化合物在口腔鳞状细胞癌中的分子靶点
Cancers (Basel). 2024 Oct 26;16(21):3612. doi: 10.3390/cancers16213612.
7
Repurposing Drugs for Cancer Prevention: Targeting Mechanisms Common to Chronic Diseases.药物再利用预防癌症:针对慢性疾病的共同机制。
Cancer J. 2024;30(5):345-351. doi: 10.1097/PPO.0000000000000746.
8
Discovery of Natural Products for Cancer Prevention.天然产物在癌症预防中的应用。
Cancer J. 2024;30(5):313-319. doi: 10.1097/PPO.0000000000000745.
9
Advancements and recent explorations of anti-cancer activity of chrysin: from molecular targets to therapeutic perspective.白杨素抗癌活性的研究进展与近期探索:从分子靶点到治疗前景
Explor Target Antitumor Ther. 2024;5(3):477-494. doi: 10.37349/etat.2024.00230. Epub 2024 May 23.
10
Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer.植物源天然产物抗耐药性癌症的研究进展。
Nutrients. 2024 Mar 11;16(6):797. doi: 10.3390/nu16060797.
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.
4
Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.糖尿病与癌症:癌症应纳入常规糖尿病评估筛查。
Diabetes Metab J. 2019 Dec;43(6):733-743. doi: 10.4093/dmj.2019.0177.
5
Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.女性原发性乳腺癌风险降低的药物治疗:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2019 Sep 3;322(9):868-886. doi: 10.1001/jama.2019.5780.
6
Immune Activation in Mismatch Repair-Deficient Carcinogenesis: More Than Just Mutational Rate.错配修复缺陷型肿瘤发生中的免疫激活:不止是突变率那么简单。
Clin Cancer Res. 2020 Jan 1;26(1):11-17. doi: 10.1158/1078-0432.CCR-18-0856. Epub 2019 Aug 5.
7
General Aspects of Primary Cancer Prevention.原发性癌症预防的一般方面。
Dig Dis. 2019;37(5):406-415. doi: 10.1159/000497191. Epub 2019 Feb 15.
8
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine.癌症免疫检查点治疗反应的基因组学:对精准医学的启示。
Genome Med. 2018 Nov 29;10(1):93. doi: 10.1186/s13073-018-0605-7.
9
The Marriage Between Genomics and Immunotherapy: Mismatch Meets Its Match.基因组学与免疫疗法的联姻:不匹配遇上了它的匹配。
Oncologist. 2019 Jan;24(1):1-3. doi: 10.1634/theoncologist.2017-0519. Epub 2018 Oct 23.
10
Cancer immunoprevention: from mice to early clinical trials.癌症免疫预防:从老鼠到早期临床试验。
BMC Immunol. 2018 Jun 15;19(1):16. doi: 10.1186/s12865-018-0253-0.